PI
NUVB icon

Putnam Investments’s Nuvation Bio NUVB Stock Holding History

Putnam Investments’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$230K Buy
+152,164
New +$196K ﹤0.01% 1124

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Putnam Investments's NUVB Position: Q4 2023 in Review

Putnam Investments opened a new position in Nuvation Bio (NUVB) in Q4 2023: 152,164 shares worth $230K. The stake represents ﹤0.01% of the portfolio and ranks #1124 among its holdings.

116 funds tracked by Wall St. Rank hold NUVB as of Q4 2023.

  • Putnam Investments held 152,164 shares of Nuvation Bio worth $230K as of Q4 2023.
  • Nuvation Bio was a new Putnam Investments position in Q4 2023.
  • Nuvation Bio made up ﹤0.01% of Putnam Investments's portfolio in Q4 2023, its #1124 holding.
  • 116 funds tracked by Wall St. Rank held Nuvation Bio as of Q4 2023.

Based on Putnam Investments's 13F filing for Q4 2023, filed 14 Feb 2024.